Attached files
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT
OF 2002
In connection with
the Annual Report of FluoroPharma Medical, Inc. (the
"Company") on Form 10-K for the year ended December 31,
2016 as filed with the Securities and Exchange Commission on the
date hereof (the "Report"), I, Thomas H. Tulip, President and Chief
Executive Officer of the Company, certify, pursuant to 18 U.S.C.
Sec. 1350, as adopted pursuant to Sec. 906 of the
Sarbanes-Oxley Act of 2002, that:
(1)
The Report fully complies with the requirements of
Section 13(a) or 15(d) of the Securities Exchange Act of 1934;
and
(2)
The information contained in the Report fairly presents, in all
material respects, the financial condition and results of
operations of the Company
March 31, 2017
/s/ Thomas H. Tulip
Thomas
H. Tulip, Ph.D.
President
and Chief Executive Officer
(Principal
Executive Officer)